Study designs: all MPD measure sets of study design type timecourse

timecourse = timecourse, same cohort

Select table page: First Prev Next Last
   FILTER RESULTS BY:
Data set Clear All
Procedure / Protocol Clear All
Drug or Challenge Clear All
Panel Clear All
Sex Clear All
Data set MPD ID Procedure / Protocol Drug or Challenge Phenotype Measure Panel No. of Strains Sex Age Sample Size (Avg) Year
    Bennett1 36701 body weight (none) body weight   [g]     age (days):    30    60    90    120    150    180 ILSXISS 96 f 4wks N=5 2005
    Bennett3 37501 alcohol quantification ethanol blood ethanol concentration (BEC)   [mg/mL]     first loss of balance (ataxia)    first regain of balance    second regain of balance ILSXISS w/par 72 both 8-14wks N=5 2007
    Cheverud1 17801 body weight (none) body weight on control diet   [g]     age (wks):    4    5    6    7    9    11    15    19    23 LGXSM w/par 17 both N=8 2004
    Cheverud1 17851 body weight high-fat diet body weight on high-fat diet   [g]     age (wks):    4    5    6    7    9    11    15    19    23 LGXSM w/par 18 both N=8 2004
    Crabbe4 19112 alcohol quantification ethanol blood ethanol concentration   [mg/mL]     time after ethanol:    30min    60min    105min    150min inbred 21 both 7-12wks N=6 2003
    Crowley1 39401 body weight haloperidol body weight   [g]     starting    ending inbred w/CC8 27 m 9-28wks N=6 2012
    Crowley1 39403 drug and metabolite quantification haloperidol plasma haloperidol concentration   [nM]     day:    30    60    90    120 inbred w/CC8 27 m 9-28wks N=6 2012
    Crowley1 39407 inclined screen test haloperidol latency to move four paws (extrapyramidal side effects)   [s]     day:    0    3    7    30    60    120 inbred w/CC8 27 m 9-28wks N=6 2012
    Crowley1 39412 open field test haloperidol distance traveled (60 min test)   [cm]     day:    0    30    60    120 inbred w/CC8 27 m 9-28wks N=6 2012
    Crowley1 39417 open field test haloperidol vertical activity (beam breaks, 60 min test)   [n]     day:    0    30    60    120 inbred w/CC8 27 m 9-28wks N=6 2012
    Crowley1 39421 open field test haloperidol repetitive behavior (breaking of same beam, 60 min test)   [n]     day:    0    30    60    120 inbred w/CC8 27 m 9-28wks N=6 2012
    Crowley1 39425 open field test haloperidol center occupancy, percent of total time   [%]     day:    0    30    60    120 inbred w/CC8 27 m 9-28wks N=6 2012
    Crowley1 39429 behavior observation haloperidol tongue protrusions (15 min test)   [n]     day:    0    30    60    120 inbred w/CC8 27 m 9-28wks N=6 2012
    Crowley1 39433 behavior observation haloperidol overt chewing movements (15 min test)   [n]     day:    0    30    60    120 inbred w/CC8 27 m 9-28wks N=6 2012
    Crowley1 39437 behavior observation haloperidol subtle chewing movements (15 min test)   [n]     day:    0    30    60    120 inbred w/CC8 27 m 9-28wks N=6 2012
    Crowley1 39441 behavior observation haloperidol jaw tremor duration (15 min test)   [s]     day:    0    30    60    120 inbred w/CC8 27 m 9-28wks N=6 2012
    Eumorphia3 26411 glucose tolerance (none) glucose levels during glucose tolerance test (20% glucose oral, 16h fast, age 12wks)   [mg/dL]     minutes:    0    30    60    90    120    180 inbred 3 both 12wks N=10 2008
    Eumorphia3 26421 glucose tolerance (none) glucose levels during glucose tolerance test (20% glucose oral, 16h fast, age 24wks)   [mg/dL]     minutes:    0    30    60    90    120    180 inbred 4 both 24wks N=8 2008
    Eumorphia3 26431 glucose tolerance (none) glucose levels during glucose tolerance test (20% glucose oral, 16h fast, age 52wks)   [mg/dL]     minutes:    0    30    60    90    120    180 inbred 4 both 52wks N=8 2008
    Eumorphia5 26601 body temperature (none) body temperature (rectal) in cold (4°C) room   [°C]     hours exposed to cold:    0    1    2    3    4    5    6 inbred 4 both 12wks N=10 2008
    Evsikova1 24701 body weight (none) body weight   [g]     test start    test end    change inbred 12 both 26wks N=7 2009
    Evsikova1 24766 intake monitoring (none) food intake adjusted for body weight   [g/kg]     test start    test end inbred 12 both 26wks N=6 2009
    Jax1 3604 body weight (none) body weight   [g]     age (wks):    3    4    5    6    7    8    9    10 inbred 20 both 3wks N=40 2000
    Jaxpheno5 23001 body weight (none) body weight   [g]     age (wks):    3    4    5    6    7    8    9    10    11    12    13    14    15    16    inbred 9 both N=90 2014
    McMullan2 60501 running wheel monitoring (none) total distance   [m]     day: 1    4    8    12    16    20    24    28 CC 42 f 5-22wks N=4 2017
    McMullan2 60521 running wheel monitoring (none) total duration   [min]     day: 1    4    8    12    16    20    24    28 CC 42 f 5-22wks N=4 2017
    McMullan2 60541 running wheel monitoring (none) mean speed   [m/min]     day: 1    4    8    12    16    20    24    28 CC 42 f 5-22wks N=4 2017
    McMullan3 60611 body weight and size (none) body weight   [g]     start    2 wks    4 wks CC 43 f 5-22wks N=4 2017
    McMullan3 60621 MRI (none) percentage of body mass that is fat   [%]     start    2 wks    4 wks CC 43 f 5-22wks N=4 2017
    McMullan3 60631 MRI (none) percentage of body mass that is lean   [%]     start    2 wks    4 wks CC 43 f 5-22wks N=4 2017
    McMullan3 60641 body weight and size (none) body weight response   [%]     start to 2 wks    2 wks to 4 wks    start to 4 wks CC 43 f 5-22wks N=4 2017
    McMullan3 60651 MRI (none) fat mass response   [%]     start to 2 wks    2 wks to 4 wks    start to 4 wks CC 43 f 5-22wks N=4 2017
    McMullan3 60661 MRI (none) lean mass response   [%]     start to 2 wks    2 wks to 4 wks    start to 4 wks CC 43 f 5-22wks N=4 2017
    McMullan3 60671 intake monitoring (none) food intake   [g]     start to 2 wks    2 wks to 4 wks CC 43 f 5-22wks N=4 2017
    Metten1 16501 open field test ethanol line crossings, 2.75 g/kg i.p.   [n]     pre-injection    10min after injection    30min after inbred 9 both 8-11wks N=4 2004
    Metten1 16502 open field test ethanol line crossings, 3.0 g/kg i.p.   [n]     pre-injection    10min after injection    30min after inbred 9 both 8-11wks N=4 2004
    Metten1 16509 behavior observation ethanol hindlimb splay, 2.75 g/kg i.p.   [score]     10min after injection    30min after inbred 9 both 8-11wks N=4 2004
    Metten1 16511 behavior observation ethanol hindlimb splay, 3.0 g/kg i.p.   [score]     10min after injection    30min after inbred 9 both 8-11wks N=4 2004
    Metten1 16513 behavior observation ethanol erratic gait, 2.75 g/kg i.p.   [score]     10min after injection    30min after inbred 9 both 8-11wks N=4 2004
    Metten1 16515 behavior observation ethanol erratic gait, 3.0 g/kg i.p.   [score]     10min after injection    30min after inbred 9 both 8-11wks N=4 2004
    Odet2 53808 microscopy (none) percent of sperm that are motile   [%]     min:    10    30    60    90    120 inbred w/CC8 8 m 10-66wks N=13 2015
    Odet2 53815 microscopy (none) percent of motile sperm that are 'progressive'   [%]     min:    10    30    60    90    120 inbred w/CC8 8 m 10-66wks N=13 2015
    Odet2 53821 microscopy (none) percent of motile sperm that are 'intermediate'   [%]     min:    10    30    60    90    120 inbred w/CC8 8 m 10-66wks N=13 2015
    Odet2 53828 microscopy (none) percent of motile sperm that are 'hyperactivated'   [%]     min:    10    30    60    90    120 inbred w/CC8 8 m 10-66wks N=13 2015
    Odet2 53835 microscopy (none) percent of motile sperm that are 'vigorous'   [%]     min:    10    30    60    90    120 inbred w/CC8 8 m 10-66wks N=13 2015
    Odet2 53841 microscopy (none) percent of motile sperm that are 'slow'   [%]     min:    10    30    60    90    120 inbred w/CC8 8 m 10-66wks N=13 2015
    Odet2 53848 microscopy (none) percent of motile sperm that are 'weak'   [%]     min:    10    30    60    90    120 inbred w/CC8 8 m 10-66wks N=13 2015
    Odet2 53855 microscopy (none) sperm mean path velocity   [µm/s]     min:    10    30    60    90    120 inbred w/CC8 8 m 10-66wks N=13 2015
    Odet2 53861 microscopy (none) sperm mean straight line velocity   [µm/s]     min:    10    30    60    90    120 inbred w/CC8 8 m 10-66wks N=13 2015
    Odet2 53868 microscopy (none) sperm mean curvilinear velocity   [µm/s]     min:    10    30    60    90    120 inbred w/CC8 8 m 10-66wks N=13 2015
    Odet2 53875 microscopy (none) sperm mean lateral head displacement (amplitude)   [µm]     min:    10    30    60    90    120 inbred w/CC8 8 m 10-66wks N=13 2015
    Odet2 53881 microscopy (none) sperm mean cross beat frequency   [Hz]     min:    10    30    60    90    120 inbred w/CC8 8 m 10-66wks N=13 2015
    Odet2 53888 microscopy (none) sperm mean straightness   [ratio]     min:    10    30    60    90    120 inbred w/CC8 8 m 10-66wks N=13 2015
    Odet2 53894 microscopy (none) sperm mean linearity   [ratio]     min:    10    30    60    90    120 inbred w/CC8 8 m 10-66wks N=13 2015
    Schonfeld1 32303 glucose tolerance (none) glucose levels during glucose tolerance test(10% glucose i.p., 5h fast)   [mg/dL]     0min    30min    60min    120min inbred 10 both 9-13wks N=5 2005
    Schonfeld1 32308 glucose tolerance (none) glucose levels, area under curve, glucose tolerance test (10% glucose i.p., 5h fast)   [AUC]     0 to 60min    0 to 120min inbred 10 both 9-13wks N=5 2005
    Schonfeld1 32313 insulin tolerance (none) glucose levels as percent of baseline, insulin tolerance test (human insulin 0.75 U/kg bw i.p., 5h fast)   [%]     0min    30min    60min    120min inbred 10 both 9-13wks N=5 2005
    Schonfeld1 32318 insulin tolerance (none) glucose levels, area under curve, insulin tolerance test (human insulin 0.75 U/kg bw i.p., 5h fast)   [AUC]     0 to 60min    0 to 120min inbred 10 both 9-13wks N=5 2005
    Schughart1 39301 body weight influenza A (H1N1) virus body weight as percent of baseline   [%]     day 1    day 3    day 7    day 12 inbred 9 both 10-12wks N=10 2009
    Schughart2 49602 body weight influenza A (H1N1) virus body weight as percent of baseline   [%]     day 1    day 3    day 7 BXD w/par 56 f 9-18wks N=6 2012
    Schughart3 57111 body weight influenza A (H3N2) virus body weight as percent of baseline, 10 FFU group   [%]     days post-infection:    1    2    3    4    5    6    7    8    9    10    11    12    13    14 inbred w/CC8 8 both 7-13wks N=9 2013
    Schughart3 57131 body weight influenza A (H3N2) virus body weight as percent of baseline, 2000 FFU group   [%]     days post-infection:    1    2    3    4    5    6    7    8    9    10    11    12    13    14 inbred w/CC8 8 both 7-13wks N=9 2013
    Schughart3 57151 body weight influenza A (H3N2) virus body weight as percent of baseline, 200,000 FFU group   [%]     days post-infection:    1    2    3    4    5    6    7    8    9    10    11    12    13    14 inbred 2 both 7-13wks N=12 2013
    Schughart4 58711 body weight (none) body weight as percent of baseline, control (saline) group   [%]     days post-treatment (saline):    1    2    3 inbred w/CC8 8 f 8-12wks N=6 2016
    Schughart4 58721 body weight influenza A (H3N2) virus body weight as percent of baseline, infected group   [%]     days post-infection:    1    2    3    4    5    6    7    8    9    10    11    12    13    14    18    30 inbred w/CC8 8 f 8-12wks N=11 2016
    Schughart4 58743 complete blood count influenza A (H3N2) virus white blood cell count (WBC), treated group   [n/µL]     days post-infection:    3    5    8    18    30 inbred w/CC8 8 f 8-12wks N=6 2016
    Schughart4 58753 complete blood count influenza A (H3N2) virus lymphocyte differential, treated group   [%]     days post-infection:    3    5    8    18    30 inbred w/CC8 8 f 8-12wks N=6 2016
    Schughart4 58763 complete blood count influenza A (H3N2) virus monocyte differential, treated group   [%]     days post-infection:    3    5    8    18    30 inbred w/CC8 8 f 8-12wks N=6 2016
    Schughart4 58773 complete blood count influenza A (H3N2) virus granulocyte differential, treated group   [%]     days post-infection:    3    5    8    18    30 inbred w/CC8 8 f 8-12wks N=6 2016
    Schughart4 58783 in vitro assay influenza A (H3N2) virus viral load in lungs (titer, FFU per lung) log10 (x+1)   [log(n)]     days post-infection:    3    5    8 inbred w/CC8 8 f 8-12wks N=5 2016
    Schughart5 58811 body weight (none) body weight as percent of baseline   [%]     days post-treatment (saline):    1    2    3 inbred w/CC8 8 f 8-12wks N=4 2016
    Schughart5 58821 body weight influenza A (H3N2) virus body weight as percent of baseline, 10 FFU group   [%]     days post-infection:    1    2    3    4    5    6    7    8    9    10    11    12    13    14    18    30 inbred w/CC8 8 f 8-12wks N=9 2016
    Seburn1 9205 body weight (none) body weight   [g]     start    end    Δchange inbred 16 both 7-9wks N=8 2001
    Threadgill2 39609 drug and metabolite quantification acetaminophen serum acetaminophen (APAP)   [µg/mL]     baseline    0.5h    1h    2h    3h    6h inbred 5 m 6-8wks N=5 2005
    Threadgill2 39616 drug and metabolite quantification acetaminophen serum acetaminophen sulfate (APAP-sulfate)   [µg/mL]     baseline    0.5h    1h    2h    3h    6h inbred 5 m 6-8wks N=5 2005
    Threadgill2 39622 drug and metabolite quantification acetaminophen serum acetaminophen glucuronide (APAP-Glc)   [µg/mL]     baseline    0.5h    1h    2h    3h    6h inbred 5 m 6-8wks N=4 2005
    Threadgill2 39632 drug and metabolite quantification acetaminophen serum acetaminophen (APAP)   [µg/mL]     baseline    0.5h    1h    2h    3h    6h inbred 5 m 6-8wks N=5 2005
    Threadgill2 39638 drug and metabolite quantification acetaminophen serum acetaminophen sulfate (APAP-sulfate)   [µg/mL]     baseline    0.5h    1h    2h    3h    6h inbred 5 m 6-8wks N=5 2005
    Threadgill2 39639 drug and metabolite quantification acetaminophen serum acetaminophen glucuronide (APAP-Glc)   [µg/mL]     baseline    0.5h    1h    2h    3h    6h inbred 5 m 6-8wks N=5 2005
    Wahlsten1 10820 open field test (none) distance traveled in 1 min   [cm]     during minute:    1    2    3    4    5 inbred 21 both 9wks N=10 2003
    Wahlsten1 10840 elevated plus maze (none) distance traveled in 1 min   [cm]     during minute:    1    2    3    4    5 inbred 21 both 9wks N=9 2003
    All boxes             To see more rows use the paging control at top.